Results · Apr-Jun 2026
Chemo Pharma Laboratories Q1 FY27 results
Sales were ₹0.07 crore against ₹0 crore in Apr-Jun 2025.
Operating profit was ₹0.02 crore, an operating margin of 28.3%.
Net profit turned positive: ₹0.02 crore against a loss of ₹11.8 crore in Apr-Jun 2025.
Against Jan-Mar 2026: net profit turns positive.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.1 | 0.0 | n/m |
| Operating profit (EBITDA) | 0.0 | -11.8 | n/m |
| Operating margin | 28.3% | - | - |
| Net profit | 0.0 | -11.8 | turns positive |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.